ArkeaBio vs Hoppscotch
Side-by-side comparison of AI visibility scores, market position, and capabilities
$40M+ total raised including $26.5M Series A. 2026-27 cattle field trials underway. Backed by Breakthrough Energy Ventures. Only company with a cattle methane vaccine in active trials.
About
ArkeaBio is developing a vaccine that reduces methane emissions from cattle and sheep by targeting the methanogenic archaea (ancient microorganisms) that produce methane in ruminant digestive systems. The company has raised $40 million+ including a $26.5 million Series A, backed by Breakthrough Energy Ventures and Gates Foundation-aligned capital, and has active cattle field trials underway in 2026-2027 — making it the only company with a livestock methane vaccine at this stage of clinical development.
Open-source browser-based API testing platform with 500K+ developers; $3M seed from OSS Capital competing with Postman as a lightweight, self-hostable alternative for REST and GraphQL testing.
About
Hoppscotch is an open-source API development and testing platform — providing a web-based, lightweight alternative to Postman and Insomnia for building, testing, and documenting REST, GraphQL, WebSocket, and gRPC APIs. Founded in 2019 by Liyas Thomas and Andrew Bastin in Kochi, India, Hoppscotch has grown to 500,000+ developers globally using the platform, raised $3 million in seed funding led by OSS Capital with participation from Automattic (WordPress.com parent), and offers a free open-source version alongside Hoppscotch Pro cloud with team collaboration and private workspaces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.